Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 3 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.78B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by ImmunityBio, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
3 filings
2 insiders, $3.56M in total
Insiders trading
2
Net value
−$3.56M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for ImmunityBio, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for ImmunityBio, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Cohen CherylDirector125,386Jul 6, 20262
Selecky ChristobelDirector0Jul 6, 20265
Simon Barry J.Director2,802,788Jun 26, 20265
Clark WesleyDirector8,000Jun 10, 20261
Wendel BruceDirector–Jun 10, 20262
Blaszyk Michael DDirector71,915IndirectJun 10, 20261
Maxwell LindaDirector–Jun 10, 20261
Soon-Shiong PatrickSee remarks251,018,873IndirectApr 2, 20263
California Capital Equity, LLC10% Owner251,018,873IndirectApr 2, 20263
MP 13 Ventures, LLC10% Owner251,018,873IndirectApr 2, 20263
Cambridge Equities, LP10% Owner251,018,873IndirectApr 2, 20263
Nant Capital, LLC10% Owner251,018,873IndirectApr 2, 20263
Lauer Regan JChief Accounting Officer115,875Feb 24, 20262
Adcock RichardCEO & President560,344Feb 24, 20263
Sachs David C.Chief Financial Officer300,143Feb 24, 20263
Brennan John OwenDirector25,000Jun 13, 20240

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jul 6, 2026 (view filing)8:26 PM ETJul 24 daysCohen CherylDirectorSSale−131.2K$9.50−$1.25M−51.1%125.4K after10b5-1
Jul 6, 2026 (view filing)8:25 PM ETJul 15 daysSelecky ChristobelDirectorSSale−159.5K$9.02−$1.44M−100.0%0 after10b5-1
Jul 1, 2026 (view filing)5:04 PM ETJun 29-302 daysSelecky ChristobelDirectorSSale−96.7K$9.01−$871.2K−100.0%0 after2 lots10b5-1
Jun 26, 2026 (view filing)Jun 242 daysSimon Barry J.DirectorSSale−25.0K$7.88−$197.0K−0.9%2.80M after10b5-1
Jun 5, 2026 (view filing)Jun 41 daySimon Barry J.DirectorSSale−23.0K$7.18−$165.4K−0.8%2.83M after10b5-1
Feb 26, 2026 (view filing)Feb 242 daysSimon Barry J.DirectorSSale−75.0K$12.01−$900.8K−2.6%2.85M after10b5-1
Feb 24, 2026 (view filing)Feb 231 daySelecky ChristobelDirectorSSale−25.0K$10.00−$250.0K−100.0%0 after10b5-1
Feb 24, 2026 (view filing)Feb 20-234 daysSimon Barry J.DirectorSSale−175.0K$10.19−$1.78M−5.6%2.93M after2 lots10b5-1
Jan 21, 2026 (view filing)Jan 16-205 daysSelecky ChristobelDirectorSSale−75.0K$5.84−$437.8K−100.0%0 after2 lots10b5-1
Jan 21, 2026 (view filing)Jan 201 daySimon Barry J.DirectorSSale−152.0K$7.20−$1.09M−4.7%3.09M after2 lots10b5-1
Sep 13, 2023 (view filing)9:07 PM ETSep 112 daysSoon-Shiong Patrick and 4 othersSee remarksPPurchaseConvertible Promissory Note––––DerivativePrice outlier
Jun 5, 2023 (view filing)Jun 5Same dayBlaszyk Michael DDirectorPPurchase+71.9K$2.75+$198.0KNew position71.9K after3 lots
Jun 5, 2023 (view filing)Jun 23 daysBrennan John OwenDirectorPPurchase+25.0K$2.83+$70.7KNew position25.0K after3 lots
Jun 5, 2023 (view filing)Jun 14 daysClark WesleyDirectorPPurchase+7.00K$2.91+$20.4K+700.0%8.00K after
May 16, 2023 (view filing)May 124 daysSoon-Shiong PatrickSee remarksPPurchaseConvertible Promissory Note––––DerivativePrice outlier
Nov 8, 2022 (view filing)4:01 PM ETAug 3169 daysLateSoon-Shiong PatrickSee remarksPPurchaseAmended and Restated Convertible Promissory Note––––Derivative2 lotsPrice outlier
Nov 8, 2022 (view filing)4:01 PM ETAug 3169 daysLateSoon-Shiong PatrickSee remarksPPurchaseSecond Amended and Restated Convertible Promissory Note––––Derivative4 lotsPrice outlier
Oct 8, 2021 (view filing)Oct 8Same dayAdcock RichardCEO & PresidentPPurchase+1.93K$8.81+$17.0KNew position1.93K after2 lots
Aug 24, 2021 (view filing)Aug 20-234 daysCohen CherylDirectorSSale−24.8K$10.07−$249.5K−11.0%200.6K after2 lots
Aug 19, 2021 (view filing)Aug 17-182 daysCohen CherylDirectorSSale−45.5K$10.12−$460.6K−16.8%225.4K after2 lots